MetaCap

Acurx Pharmaceuticals (ACXP) vs Addex Therapeutics (ADXN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Acurx Pharmaceuticals is the larger company by market cap ($6.3 million vs $6.1 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACXP-20.00%ADXN+10.86%
+74%+20%-33%
Oct 7, 20261 yearNov 20, 2026
ACXP-18.11%ADXN+7.81%
+29%+1%-27%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACXP versus ADXN key metrics
MetricACXPADXN
Share price$1.04$3.47
Market cap$6.30M$6.08M
1-day change+0.97%+2.06%
EPS (TTM)$-1.90$-7.56
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-7.97M—
52-week high$7.54$10.43
52-week low$0.90$2.56
Distance from 52-week high-86.21%-66.73%
Analyst consensusstrong_buy—
Avg. price target upside+1534.62%—
Average volume97.29K383.35K
Shares outstanding6.06M1.75M
Employees43
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Acurx Pharmaceuticals

ACXP stock →

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

About Addex Therapeutics

ADXN stock →

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.

Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees

ACXP vs ADXN FAQ

Which is bigger, Acurx Pharmaceuticals or Addex Therapeutics?

Acurx Pharmaceuticals (ACXP) is larger, with a market capitalization of $6.30M compared with $6.08M for Addex Therapeutics (ADXN).

Are Acurx Pharmaceuticals and Addex Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons